Session 6
Healing: Our Path from Mental Illness to Mental Health
Presented by Tom Insel, MD
The last four decades have seen unprecedented progress in the science of mental illness, yet there has been little movement in improving the outcomes of patients. At a population level, despair, anguish, and mortality are increasing for those with schizophrenia, bipolar disorder, and severe mood and anxiety disorders. How do you explain this gap between science and social impact?
Join Tom Insel, MD, author of “Healing: Our Path from Mental Illness to Mental Health” as he discusses there is a crisis of care, the five major contributing factors and the solutions. There may not be a magic bullet but with high touch, high tech, and shifting the model from a narrow medical “sick care” approach to a broader recovery “health care” approach, the curve can be bent to make a difference.
WATCH >
Session 7
Old Friends & Mental Health: Role of Co-Evolved Micro-Organisms in Stress Resilience
Presented by Christopher Lowry
Humans have coexisted with bacteria throughout human existence on Earth. Although we often think of bacteria as causing disease, some microorganisms are beneficial for our immune systems, our bodies and our brains. As humans transitioned from hunter-gatherer societies to our modern cities, we have lost contact with some of these favorable “germs” that could help to positively influence stress-related disorders including anxiety, mood and PTSD.
Several studies demonstrate, for example, that biomarkers in active military personnel, before deployment, predict the risk of development of PTSD after deployment. At the same time, persons with PTSD have decreased numbers and function of regulatory T cells and a higher risk of developing future autoimmune disorders, which overall suggests an impaired capacity to regulate inflammation.
Associate Professor, Christopher Lowry, with the University of Colorado Boulder highlights preclinical studies and explores the idea that replacing some of these lost “Old Friends,” i.e., bacteria has the potential to improve our physical, mental and social well-being.
WATCH >
Presented by Saundra Jain, MA, PsyD, LPC
Post-holidays are a time of reflection as many focus on improving their health. After weeks of overindulging, sleeping and exercising less it is not unusual to feel tired, sad and depressed from those weeks of neglecting your health. After searching endlessly for the perfect program, it can feel disappointing when the results are lacking.
Welcome Dr. Saundra Jain, co-creator of WILD 5, a novel approach to a scientific-based wellness program that integrates social connectedness, nutrition, exercise, mindfulness, and sleep resulting in significant improvement in anxiety, depression, chronic pain and overall wellness. Dr. Jain explores the role of inflammation in depression and explains how WILD 5 might be your path to improving your wellness.
WATCH >
Session 9
Leveraging Polyvagal Theory to Enhance the Treatment of Traumatized Patients: a Conversation with Dr. Stephen Porges
Presented by Stephen Porges, PhD and Charles Raison, MD
As humans, we take for granted that—for better or worse—our lives are intimately entwined with those of others. Remember how off-putting the empty public spaces of Covid were, how unnatural, and how quickly we’ve rushed back to being packed together in so many of our activities? We should marvel at this ability because it came along late in the evolution of life in a world where most interactions involved eating, being eaten, or fighting to reproduce. How did we manage while becoming so dependent upon each other from the moment of our birth to the moment of our death?
Of all the theories that have addressed this question, none have been more impactful than Polyvagal Theory which explains how we evolved and provides explanations for why, and how, trauma—especially early in life—so often promotes depression, anxiety, and poor physical health.
Dr. Stephen Porges, creator of Polyvagal Theory, and Dr. Charles Raison, Director of the Vail Health Behavioral Innovation Center delve into the theory and examine the clinical implications of enhancing the care of patients with trauma histories.
WATCH >
Presented by Andrew Penn, MS, PMHNP and Charles Raison, MD
Some psychedelic-assisted therapies, such as MDMA for post-traumatic stress disorder and psilocybin for major depression, are either approaching the end of clinical trials or are amid clinical trials that may soon lead to FDA approval. A prescribed combination of drug plus therapy is new territory for clinicians, regulators, and patients. Because of this, the question of how these combined therapies will be administered remains an open one of some urgency.
Andrew Penn, MS, PMHN, and Charles Raison, MD will explore the implications, opportunities, and challenges of this change in how we treat mental illness from the perspective of multiple stakeholders
WATCH >
Session 11
From Mesmer to Psychedelics: Appreciating the Power of Contextual Effects
Presented by Gerard Sanacora, PhD, MD
Three steps forward, two steps back.
A person’s lifestyle and environment when receiving psychiatric care can greatly impact the effectiveness of their treatment plan. Friends, family, religion, economic, education, culture and media are just a few factors.
Gerard Sanacora, PhD, MD will explore how circumstantial factors can make a substantial difference in how well treatments work, especially regarding mental health. He will also discuss ways to manage outside influences so that patients undergoing behavioral health treatment have a higher success rate for a better outcome.
WATCH >
Session 12
Social Genomics and Human Thriving
Presented by Steven Cole, PhD
Researchers have been studying how different aspects of our lives, like our social interactions, feelings, financial situation, culture, and surroundings, can affect our genes. They’ve found that these factors including others can influence our health, development, and overall wellness.
Surprisingly it was discovered that some people thrive and show resilience to these influential factors and are not as affected as others which suggests a new perspective on the nature of “the good life” and the evolutionary basis for how our brains control our genes.
Join Steven Cole, PhD from UCLA as he explains how our growing ability to map changes in genome activity in real-time offers a form of “molecular self-awareness” that can help shape behavior and lifestyle to maximize health and well-being.
WATCH >
Session 13
Innovations in Health Learning Lab: New Hot and Cold Therapies for Depression
Presented by Ashley Mason, PhD and Charles Raison, MD
Dr. Chuck Raison and Dr. Ashley Mason discuss exciting national results from their recent research on hot and cold therapies for mental health issues and outline plans for the next phase of the CHILL’D Study at the Vail Health Behavioral Health Innovation Center.
WATCH >
Session 14
Innovations in Health Learning Lab: The Role of Spirituality in Health
Presented by Tracy Balboni, MD and Michael Balboni, PhD
Dr. Tracy Balboni and Dr. Michael Balboni presented compelling research showing how spirituality is important in patient care and holds the promise of reinvigorating how flourishing communities care for the sick.
At Vail Health, our dedicated chaplains offer compassionate spiritual care to patients, families, and staff across all facilities, including the patient care unit, intensive care unit, and Shaw Cancer Center, as well as through spiritual care integration into the Shaw at Home program. Our interfaith approach ensures support for individuals of all beliefs. Our chaplains provide emotional comfort during challenging times, serve as a calming presence, and act as liaisons to community clergy when needed.
WATCH >